1. Home
  2. CMT vs KROS Comparison

CMT vs KROS Comparison

Compare CMT & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Core Molding Technologies Inc

CMT

Core Molding Technologies Inc

HOLD

Current Price

$23.21

Market Cap

254.0M

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$10.30

Market Cap

222.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMT
KROS
Founded
1996
2015
Country
United States
United States
Employees
1239
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
254.0M
222.3M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
CMT
KROS
Price
$23.21
$10.30
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$24.00
$21.86
AVG Volume (30 Days)
21.9K
299.5K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
146.00
EPS
0.07
N/A
Revenue
$284,290,000.00
$243,864,000.00
Revenue This Year
$4.58
N/A
Revenue Next Year
$6.04
$2,751.79
P/E Ratio
$338.14
N/A
Revenue Growth
5.49
N/A
52 Week Low
$15.94
$9.79
52 Week High
$28.69
$22.55

Technical Indicators

Market Signals
Indicator
CMT
KROS
Relative Strength Index (RSI) 44.51 39.31
Support Level $22.76 $9.79
Resistance Level $25.20 $12.43
Average True Range (ATR) 0.95 0.55
MACD -0.05 -0.04
Stochastic Oscillator 30.92 29.89

Price Performance

Historical Comparison
CMT
KROS

About CMT Core Molding Technologies Inc

Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: